Dense fog will slow Friday morning commutes across metro Detroit. Late-night storms could bring heavy downpours and gusty winds into Saturday.

Bose plans a 78,000‑square‑foot automotive R&D hub in Troy's Big Beaver corridor, bringing engineering labs and vehicle test bays to Metro Detroit.

A Grosse Ile resident won $1 million in the Michigan Lottery’s Millionaire Maker second‑chance drawing at Little Caesars Arena. Finalists were chosen in a March 31 drawing and the in‑arena wheel picked the winner.

The NBA and NBPA approved an extraordinary-circumstances appeal for Cade Cunningham, restoring his eligibility for MVP and All‑NBA honors despite a late‑season collapsed lung.

A White Lake Township man accused in a January stabbing has been bound over to Oakland County Circuit Court; jail records list a $500,000 bond and an ICE hold.

Dearborn’s school board is holding public interviews for six superintendent candidates; if it hires one of four Arab American finalists, the district would get its first permanent Arab American superintendent.

Newaygo County ordered immediate evacuations Thursday for residents in the floodplain below Croton Dam as Muskegon River levels climbed toward major flood stage. Shelter was set up in White Cloud.

URGE Group has taken ownership of EBIARA Fund I, folding the Detroit‑born platform into its advisory and investment operations to widen capital access for developers of color.

A road-rage dispute outside the Traverse Area District Library left a 74-year-old with a non-life-threatening arm injury; a 70-year-old was arrested, police say.

Stellantis and Microsoft announced a five‑year partnership to co‑develop 100+ AI initiatives across engineering, customer care and manufacturing. The deal includes cloud modernization and a global cyber center.

A Washington man was sentenced to 15½ months and ordered to register as a sex offender after pleading no contest in a 2013 Electric Forest case. The arrest came after U.S. Marshals tracked him down twice.

Doug Field is leaving Ford as the automaker creates a new product creation team to centralize EV and software work. The move, reported April 15, 2026, reshapes product leadership in Dearborn.

Topline Phase 3 results show daraxonrasib extended median survival to 13.2 months versus 6.7 months for chemo, offering fresh hope in a brutal disease. Full safety and subgroup data are still pending.